Morning Overview on MSN
FDA approves J&J’s once-daily Icotyde pill for plaque psoriasis
Johnson & Johnson said the FDA approved Icotyde (icotrokinra), a once-daily oral treatment for adults with moderate to severe plaque psoriasis. In a March 18, 2026, announcement, the company described ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results